Greenwich Lifesciences Inc (GLSI) returns
Greenwich Lifesciences returns over 5 years
$1,000 invested in Greenwich Lifesciences five years ago was worth $492.36 at the close on October 30, 2026, with dividends reinvested: an average return of -13.2% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -3.5% | — | $964.54 | -0.9% |
| 3 months | +24.2% | — | $1,242 | +2.1% |
| Year to date | -17.1% | — | $828.65 | +11.7% |
| 1 year | +89.4% | — | $1,894 | +12.4% |
| 3 years | +110.3% | +28.1% | $2,103 | +88.5% |
| 5 years | -50.8% | -13.2% | $492.36 | +76.0% |
Greenwich Lifesciences return by calendar year
| Year | GLSI | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -17.1% | +11.7% | -28.8% |
| 2025 | +87.1% | +17.7% | +69.4% |
| 2024 | +6.7% | +24.9% | -18.1% |
| 2023 | -30.8% | +26.2% | -57.0% |
| 2022 | -37.5% | -18.2% | -19.4% |
| 2021 | -33.3% | +28.7% | -62.0% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also:
No forecast, no recommendation. This page describes Greenwich Lifesciences Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.